Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 10Other hematologic neoplasm 9Genitourinary 4Gastrointestinal 2

Conditions

Esophageal Stenosis 2Esophageal Neoplasms 1Barrett Esophagus 1

Interventions

Oxaliplatin 21Capecitabine 19Fluorouracil 16Bevacizumab 15Esomeprazole 11Sorafenib 10Irinotecan 9Leucovorin 8Radiofrequency Ablation 7Propofol 7Bismuth 7Morphine 6Folfox protocol 6Amoxicillin 6lenvatinib 5gadolinium ethoxybenzyl DTPA 5Tetracycline 5Sevoflurane 5S 1 (combination) 5Gemcitabine 5Drug Therapy 5Control Groups 5sodium glycididazole 4fish oil triglycerides 4ferric carboxymaltose 4Ribavirin 4Hepatectomy 4HMPL-013 4Golytely 4Furazolidone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Prednisolone × Gastrointestinal × Clear all
NCT02004782 2025-03-27

BERST

Western Sydney Local Health District

Phase 4 Withdrawn
Gastrointestinal

Barrett Esophagus, Esophageal Stenosis

NCT05768282 2023-03-16

Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia

E-DA Hospital

Phase 4 Unknown
50 enrolled
Gastrointestinal

Esophageal Neoplasms, Esophageal Stenosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡